芪龙胶囊治疗中风病中经络(气虚血瘀证)的临床研究

A Clinical Study on Qilong Capsule for Apoplexy Involving the Meridians(Qi-Deficiency and Blood-Stasis Syndrome)

目的 :评价芪龙胶囊治疗中风病中经络 (气虚血瘀证 )的临床疗效及安全性。方法 :4 0 3例患者采用随机分组、双盲双模拟对照 (治疗组 :芪龙胶囊 ,对照组 :消栓口服液 )的方法 ,其中治疗组 1 0 2例 ,对照组 1 0 1例 ,其余 2 0 0例为开放治疗组。结果 :芪龙胶囊对中风病的愈显率为 54.90 % ,总有效率为 89.2 2 % ;对中医证候的愈显率为 4 4.1 2 % ,总有效率为 89.2 2 %。芪龙胶囊治疗组优于消栓口服液对照组 (P <0 .0 1 )。结论 :芪龙胶囊治疗中风病 (气虚血瘀证 )疗效确切 。

Objective: To assess the effect and safety of Qilong Capsule (QLC) in treating apoplexy involving the meridians (Qi-deficiency and blood-stasis syndrome ). Methods: A randomized , double-blinded double-dummy controlled trial was adopted. One hundred and two patients were treated with QLC, 101 with Xiaoshuan oral liquid (XOL) and 200 served as the open treatment group. Results: The total effective rate in QLC group was 89.22% and symptomatic relieved rate 44.12%,showing that QLC was more effective than XOL(P<0.01).Conclusion: QLC is effective for apoplexy involving the meridians and has no side and toxic effects.